A carregar...
Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
Cancer remains a life-threatening disease and accounts for the major mortality rates worldwide. The practice of using biomarkers for early detection, staging, and customized therapy may increase cancer patients’ survival. Deubiquitinating enzymes (DUBs) are a family of proteases that remove ubiquiti...
Na minha lista:
| Publicado no: | BMB Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Society for Biochemistry and Molecular Biology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6476481/ https://ncbi.nlm.nih.gov/pubmed/30760385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2019.52.3.048 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|